Randomized, Controlled Multicenter Trial Demonstrates Safety and Clinical Benefit, Significant Reduction in Repeat Surgeries Enabled by Dune’s MarginProbe®

[vc_row][vc_column][vc_column_text]Company Opens US Office to Spearhead North American Operations Caesarea, Israel-Jan. 7, 2008 – Dilon Devices announces significant new clinical developments surrounding the company’s novel breast cancer assessment probe, currently in investigational use. Results from a recent randomized clinical trial in 11 medical centers in Israel have underscored the safety and clinical benefit of the…

Read More